论文部分内容阅读
1 文献来源 Reynolds C, Obasaju C, Schell M J, et al. Randomized phase IU trial of Gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer[J]. J Clin Oncol, 2009,27(34):5808-5815.